Showing 3381-3390 of 4086 results for "".
- Biologic Therapy in Psoriasis: Secukinumab and Ustekinumab Lead in Retentionhttps://practicaldermatology.com/news/biologic-therapy-in-psoriasis-secukinumab-and-ustekinumab-lead-in-retention/2471042/Switching patterns of biologics in psoriasis treatment revealed influences of gender and psoriatic arthritis (PsA), according to new research. The retrospective study from the nationwide digital prescription database of Greece has shed light on biologic treatment trends for psoriasis betwe
- Cosmetic Laser Market to Reach $14.79 Billion by 2033: Reporthttps://practicaldermatology.com/news/cosmetic-laser-market-to-reach-1479-billion-by-2033-report/2471023/The global cosmetic lasers market is projected to grow to $14.79 billion by 2033, at a compound annual growth rate (CAGR) of 14%, according to a new report from Straits Research. The analysis said the growth reflects increasing consumer interest in minimally invasive cosmetic procedures f
- Study: Safety Signals Emerge for IL-23 and IL-12/23 Inhibitors in Psoriasis Treatmenthttps://practicaldermatology.com/news/safety-signals-emerge-for-il-23-and-il-1223-inhibitors-in-psoriasis-treatment/2470971/A new analysis of psoriasis patients indicates an emergence of new safety signals associated with interleukin-23 (IL-23) inhibitors and the IL-12/23 inhibitor ustekinumab. Researchers on the study analyzed 41.4 million adverse event (AE) reports from the FDA Adverse Event Reporting System
- Study: Higher Isotretinoin Doses Reduce Acne Relapse Riskhttps://practicaldermatology.com/news/study-higher-isotretinoin-doses-reduce-acne-relapse-risk/2470951/Results from a new cohort study show higher cumulative isotretinoin dosages are associated with lower rates of acne relapse and retreatment, and that daily dosing does not influence these outcomes for patients on conventional or high cumulative doses. Authors on the study analyzed data fro
- Analysis: FDA Approvals Highlight Disparities in Oncology Outcomes by Ancestryhttps://practicaldermatology.com/news/analysis-fda-approvals-highlight-disparities-oncology-outcomes-ancestry/2470889/Patients of African ancestry remain underrepresented in eligibility for biomarker-driven precision oncology therapies, according to a new study in JAMA Dermatology. The retrospective analysis of 59,433 patients with solid cancers looked at genetic sequencing data from MSK-IMPACT a
- Study IDs Proteins Associated With Inflammatory Mechanisms of Psoriasishttps://practicaldermatology.com/news/study-ids-proteins-associated-inflammatory-mechanisms-psoriasis/2470870/A comparative analysis of dermal mesenchymal stem cell exosomes from healthy human skin and psoriatic lesions revealed 13 differential proteins, according a research published in Current Molecular Medicine. Researchers at Shanxi Medical University published “Proteomic Analysis of Mesenchym
- Higher WWI Linked to Increased Mortality Rates in Psoriasis Patientshttps://practicaldermatology.com/news/higher-wwi-linked-increased-mortality-rates-psoriasis-patients/2470869/New research indicates a strong positive correlation between weight-adjusted waist index (WWI) and all-cause mortality in psoriasis patients. Researchers at Wenzhou Medical University in China published “Weight-Adjusted Waist Index, Psoriasis, and All-Cause Mortality: Findings from the NHA
- Study: Dual-Action Topical Treatment Reduces Lesion Counts in Adult Acne Patientshttps://practicaldermatology.com/news/study-dual-action-topical-treatment-reduces-lesion-counts-adult-acne-patients/2470855/Results from a recent pilot study suggested that a combination therapy of clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel with clascoterone 1% cream was effective in reducing lesions in adult acne patients. Researchers for the study enrolled 20 adult participants with
- Study: Ongoing Inequities in Dermatology Productivity Metricshttps://practicaldermatology.com/news/study-ongoing-inequities-dermatology-productivity-metrics/2470777/A new study in JAMA Dermatology revealed that while the 2021 Medicare physician fee schedule updates reduced inequities in work relative value units (wRVUs) for outpatient dermatology visits, significant disparities based on patient demographics persist. Analyzing data from 89,656
- Study Explores How Moderate to Severe Hand Eczema Affects Quality of Lifehttps://practicaldermatology.com/news/moderate-severe-hand-eczema-quality-life-challenges-explored/2470762/Even mild hand eczema can significantly impair one's quality of life and mental health, according to a new study. The findings, presented at the recent Revolutionizing Atopic Dermatitis (RAD) Conference, spanned data collected from 2013 to 2020, addressed the outsized impact of hand eczem